| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/06/1999 | WO1999021585A1 Pharmaceutical combination of a cyclooxigenase-2 inhibitor and acetaminophen or an opiate |
| 05/06/1999 | WO1999021579A1 Solid dispersing vaccine composition for oral delivery |
| 05/06/1999 | WO1999021578A1 Insoluble insulin compositions |
| 05/06/1999 | WO1999021573A1 Fatty acid-acylated insulin analogs |
| 05/06/1999 | WO1999021567A1 Pharmaceutical compositions for oral administration of molecular iodine |
| 05/06/1999 | WO1999021562A1 Treatment of female sexual dysfunction |
| 05/06/1999 | WO1999021558A2 Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
| 05/06/1999 | WO1999021556A1 Antihistamine/decongestant regimens for treating rhinitis |
| 05/06/1999 | WO1999021551A1 Matrix for controlled delivery of highly soluble drugs |
| 05/06/1999 | WO1999021537A1 Dermatological patch sheet and process for producing base sheet therefor |
| 05/06/1999 | WO1999021536A1 Controlled release formulations |
| 05/06/1999 | WO1999021535A1 Osmotic medicament releasing system |
| 05/06/1999 | WO1999021534A1 Solid state solutions and dispersions of poorly water soluble drugs |
| 05/06/1999 | WO1999021533A2 Delivery vehicles for bioactive agents and uses thereof |
| 05/06/1999 | WO1999021531A1 β-D GLUCAN TOPICAL COMPOSITION |
| 05/06/1999 | WO1999021508A1 Administration of active agents, including 5-ht receptor agonists and antagonists, to treat premature ejaculation |
| 05/06/1999 | WO1999021507A2 Synthetic fibres for medical use and method of making the same |
| 05/06/1999 | WO1999012549A3 Controlled release microsphere delivery system |
| 05/06/1999 | WO1999008729A9 Loading and release of water-insoluble drugs |
| 05/06/1999 | WO1999008691A3 Use of locally delivered metal ions for treatment of periodontal disease |
| 05/06/1999 | WO1998055455A9 Modification of platelet action by fibrinogen-coated particles |
| 05/06/1999 | EP0913445A1 Enhancer tolerant pressure sensitive adhesives for transdermal drug delivery |
| 05/06/1999 | EP0913407A1 Chitin beads, chitosan beads, processes for producing these beads, carriers made of these beads and processes for producing microsprodidian spores |
| 05/06/1999 | EP0913406A1 Glucoamylase converted starch derivatives and their use as emulsifying and encapsulating agents |
| 05/06/1999 | EP0913178A1 Process for the manufacture of dry, amorphous products comprising biologically active material by means of convection drying and products obtainable by the process |
| 05/06/1999 | EP0913177A1 Process for producing dry, amorphous products comprising biological active materials by means of convection drying technique, especially spray drying |
| 05/06/1999 | EP0913160A2 Ligand-specific opening of a gated-porin channel in the outer membrane of living bacteria |
| 05/06/1999 | EP0913159A1 Drug delivery system using galactoxyloglucan |
| 05/06/1999 | EP0913158A1 Transdermal patch comprising a combination of two or more fatty acids or alcohols as permeation enhancers |
| 05/06/1999 | EP0913154A1 Antipsoriatic nail lacquer |
| 05/06/1999 | EP0913149A1 Drug composition with controlled drug release rate |
| 05/06/1999 | EP0913148A1 Tabletting of erythritol |
| 05/06/1999 | EP0912729A1 INHIBITION OF CHRONIC MYELOGENOUS LEUKEMIC CELL GROWTH BY LIPOSOMAL-ANTISENSE OLIGODEOXY-NUCLEOTIDES TARGETING TO Grb2 OR Crk1 |
| 05/06/1999 | EP0912627A1 Sustained release heterodisperse hydrogel systems - amorphous drugs |
| 05/06/1999 | EP0912501A1 Per(poly)fluorinated polyoxyethylated carbamates |
| 05/06/1999 | EP0912251A1 A dispensing device and method for forming material |
| 05/06/1999 | EP0912239A1 Method for providing dense particle compositions for use in transdermal particle delivery |
| 05/06/1999 | EP0912211A1 Medical devices comprising ionically and non-ionically cross-linked polymer hydrogels having improved mechanical properties |
| 05/06/1999 | EP0912203A1 Medical pressure-sensitive adhesives with high permeability to water vapour and high adhesive force, and plasters provided therewith |
| 05/06/1999 | EP0912198A1 Immunoliposomes that optimize internalization into target cells |
| 05/06/1999 | EP0912190A1 Medicaments containing plant extracts |
| 05/06/1999 | EP0912187A2 Compositions and methods for the prevention and treatment of atherosclerosis and reperfusion injury with magnesium salts |
| 05/06/1999 | EP0912169A2 $g(b)-LACTAM GRANULES FREE OF ORGANIC SOLVENTS |
| 05/06/1999 | EP0912168A2 Ephedrine in granular form with a high active substance content |
| 05/06/1999 | EP0912167A1 Granulates of hexahydropyrazine derivatives which can be administered orally |
| 05/06/1999 | EP0912166A1 Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients |
| 05/06/1999 | EP0912162A1 Solid oral anticariogenic composition for cleaning the buccal cavity and teeth, and process for preparing this composition |
| 05/06/1999 | EP0735860B1 Novel foaming compositions, particularly for rectal foams, and resulting foams |
| 05/06/1999 | EP0713388B1 A method for high loading of vesicles with biopolymeric substances |
| 05/06/1999 | EP0676953B1 Plasticized bioerodible controlled delivery system |
| 05/06/1999 | EP0656203B1 Injectable microfoam containing a sclerosing agent |
| 05/06/1999 | EP0634171B1 Pharmaceutical composition for treating cerebral thrombosis |
| 05/06/1999 | EP0574571B1 Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation |
| 05/06/1999 | EP0570519B1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 05/06/1999 | DE19748796A1 Verfahren zur Herstellung von Liposomen A process for the preparation of liposomes |
| 05/06/1999 | DE19748545A1 Production of aqueous copolymer dispersions |
| 05/06/1999 | CA2348922A1 Polymeric systems for drug delivery and uses thereof |
| 05/06/1999 | CA2307863A1 Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharmaceutical compositions |
| 05/06/1999 | CA2307790A1 Antihistamine/decongestant regimens for treating rhinitis |
| 05/06/1999 | CA2306905A1 Fatty acid-acylated insulin analogs |
| 05/06/1999 | CA2306877A1 Insoluble insulin compositions |
| 05/06/1999 | CA2306090A1 Delivery vehicles for bioactive agents and uses thereof |
| 05/06/1999 | CA2305293A1 Administration of active agents, including 5-ht receptor agonists and antagonists, to treat premature ejaculation |
| 05/06/1999 | CA2304815A1 .beta.-d glucan topical composition |
| 05/06/1999 | CA2275539A1 A transdermal patch and a method for manufacture of a substrate sheet therefor |
| 05/05/1999 | CN1215993A Pharmaceutical formulations |
| 05/05/1999 | CN1215991A Enteric-coated pharmaceutical compositions of mycophenolate |
| 05/05/1999 | CN1215989A Dosage form of ibuprofen |
| 05/05/1999 | CN1215988A Ophthalmic compound with extended dwell time on eye |
| 05/05/1999 | CN1215986A Methods for preparing gas-filled liposomes |
| 05/05/1999 | CN1215607A Effective fast-acting plaster |
| 05/05/1999 | CN1215598A Capsule for nourishing kidney and strengthening Yang |
| 05/05/1999 | CN1215596A Baby umbilicus warming plaster |
| 05/05/1999 | CN1215593A High active calcium tablet and producing process thereof |
| 05/05/1999 | CN1215591A Chroman derivative-containing ophthalmic solution |
| 05/05/1999 | CN1215590A Albendazole suspension for expelling and controlling parasite in livestock, and preparing process thereof |
| 05/05/1999 | CN1215589A Intra-articular preparation for treatment of arthropathy |
| 05/05/1999 | CN1215588A Multifunctional health eye moistening atriphos liquid and preparing method thereof |
| 05/05/1999 | CN1043189C Method for preparing prolonged release preparation |
| 05/04/1999 | US5900431 Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections |
| 05/04/1999 | US5900425 Containing release delay gel polymer |
| 05/04/1999 | US5900424 Omeprazole magnesium salt form |
| 05/04/1999 | US5900419 Solution or suspension of camptothecin derivative in n-methyl-2-pyrrolidone, pharmaceutically acceptable acid, polyethylene glycol, lower alcohol or benzyl alcohol |
| 05/04/1999 | US5900412 Percutaneous/transdermal delivery of ASA and antithrombotic therapies based thereon |
| 05/04/1999 | US5900408 Sustained release |
| 05/04/1999 | US5900407 Method of treating dry eye disease with uridine triphosphates and related compounds |
| 05/04/1999 | US5900252 Multidose minitablet drug cores surrounded by a first polymeric membrane soluble at ph above 5.5 and an outer insoluble membrane which is permeable to gastric fluids, for timed release in ileum or colon |
| 05/04/1999 | US5900251 Gelatin capsule containing herb extract |
| 05/04/1999 | US5900250 Monoglyceride/lactate ester permeation enhancer for oxybutnin |
| 05/04/1999 | US5900248 Nutrients |
| 05/04/1999 | US5900247 Mucoadhesive pharmaceutical composition for the controlled release of active principles |
| 05/04/1999 | US5900245 Compliant tissue sealants |
| 05/04/1999 | US5900238 Vaccine delivery system |
| 05/04/1999 | US5900230 Synergistic mixtures of poloxomers and xylitol which are free of irritating detergents, flavors and antiseptics, for dentifrice pastes, gels, lozenges, chewing gums or mouthwashes |
| 05/04/1999 | US5900229 Use of a vinyl lactam-derived terpolymer as a foaming agent in compositions forming an aerosol foam |
| 05/04/1999 | CA2180424C Drugs, vaccines and hormones in polylactide coated microspheres |
| 05/04/1999 | CA2063689C Ibuprofen lysinate pharmaceutical formulation |
| 05/04/1999 | CA1340529C Pediatric ibuprofen compositions |
| 05/04/1999 | CA1340526C Interaction system comprising a surfactant-stabilized disperse aqueous phase containing an antibody or antibody fragment |
| 04/30/1999 | CA2252314A1 Use of an enzymatically converted starch derivative as an encapsulating agent |